glp-1 and family history of thyroid cancer There is no conclusive evidence linking medications to in the general population. But for people with certain rare syndromes the risk picture is different, which is why these Glucagon‐like peptide‐1 receptor agonists and

Adding cagrilintide to tirzepatide Theoretical protocol (not clinically studied): If on tirzepatide 10-15mg: Stable on tirzepatide for 4+ weeks Continue tirzepatide at current dose Add cagrilintide 0.6mg weekly Standard cagrilintide titration to 2.4mg Rationale: Tirzepatide is dual GIP/GLP-1 (very powerful alone) Adding amylin pathway could theoretically enhance No clinical data on this combination Uncertain if additional benefit over tirzepatide alone Concerns: GI side effects may be severe (both slow gastric emptying) Tirzepatide already produces 15-22% weight loss alone Unclear if cagrilintide adds meaningful benefit Expensive combination Verdict: Wait for clinical data

To stay hydrated: Aim to drink 68 glasses of water per day, or more if you are physically active

Dry hair

FDA review takes 1012 months, putting likely approval at late 2027 and US market launch at early-to-mid 2028

Yes, rosacea can occur in all skin types, including dark skin

DSM-5 field trials in the United States and Canada, part II: test-retest reliability of selected categorical diagnoses